CU-CPD107 is a potent and selective Toll-like receptor 8 (TLR8) agonist; it inhibits TLR8 signaling pathway, exhibits cooperative agonist activity in the presence of ssRNA to induce TLR8 signal transduction, and suppresses pro-inflammatory cytokine expression to prevent immune responses triggered by ssRNA.